Pharming Group (NASDAQ:PHAR) executives said first-quarter 2026 results reflected an expected decline in RUCONEST revenue tied largely to specialty pharmacy inventory movements and the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results